On September 8, 2026, Greenland Mines Ltd. announced that directors Shalom Hirschman and Riad El-Dada resigned from the Board of Directors. The company stated that neither resignation resulted from any disagreement with management regarding operations or policies. Simultaneously, the Board appointed Jason Hawkins as a new director to fill the resulting vacancy, effective immediately. Mr. Hawkins brings over 25 years of capital markets experience and serves as Chairman and CEO of Intrusion Precious Metals Corp., which is a significant minority shareholder of Greenland Mines. He will serve until the next annual meeting of stockholders. Greenland Mines Ltd. operates in the mining industry, focusing on precious metals and critical minerals.

Greenland Mines Ltd completed the acquisition of Greenland Rare Earths Corp., resulting in the indirect transfer of the Sarfartoq mineral project license. The transaction closed on September 1, 2026, with consideration consisting of 1,040,676 shares of common stock and 359,324 newly designated Series R preferred shares issued to former Neo North Star Resources stockholders via NNSR Holdings Inc. An independent Initial Assessment for Sarfartoq indicates a high-case pre-tax net present value of approximately $2.05 billion and an internal rate of return of 118.6%. Concurrently, the company designated Series R Preferred Stock, convertible to common shares upon stockholder approval, and amended Series C Preferred conversion rights to limit exercise until January 8, 2027, or a Nasdaq closing price of $15.00 for five consecutive days. Greenland Mines Ltd operates in the mining industry, focusing on rare earth mineral exploration and development.

On July 21, 2026, Greenland Mines Ltd. declared a dividend of one right for each outstanding share of Common Stock, payable on August 7, 2026, to stockholders of record as of that date. This establishes a limited-duration stockholder rights plan (poison pill) effective July 22, 2026, expiring July 22, 2027. The rights become exercisable if a person or group acquires 15% or more of outstanding common shares, allowing holders to purchase shares at an exercise price of $0.75. The plan includes flip-in and flip-over triggers to discourage coercive takeover tactics. The company operates in the mining and biotech industries, focusing on rare earth and precious metals exploration in Greenland and ALS therapeutic development.

Greenland Mines Ltd announced the completion of a Technical Report Summary (TRS) for the Skaergaard project in southeast Greenland, marking its first S-K 1300-compliant report. An updated 2026 Mineral Resource Estimate (MRE) shows a 31% increase in Indicated PdEq contained metal (11.41 Moz to 15.00 Moz) and a 24% increase in Inferred PdEq contained metal (14.11 Moz to 17.49 Moz) compared to 2022. Indicated PdEq grade rose 36% to 3.04 g/t, and Inferred PdEq grade rose 44% to 3.07 g/t. These upgrades were driven by an improved geological block model and updated metal prices, including gold at $3,500/oz. The company intends to use this regulatory foundation to proceed toward an Initial Assessment evaluating open-pit and underground mining scenarios. The company operates in the mining and biotech industries, focusing on the exploration and development of precious and critical metals.

On July 4, 2026, Greenland Mines Ltd. terminated its At-the-Market Sales Agreement with A.G.P./Alliance Global Partners that had been in place since July 3, 2025. The company terminated the agreement as of right without incurring any penalties, and no shares remained available for sale under the agreement. The company operates in the mining industry, focusing on mineral exploration and extraction.